$CRMD· SEC filing ·

CRMD Q1 2026 Revenue $127.4M, Net Income $38.6M, Diluted EPS $0.43

CorMedix Inc. · PHARMACEUTICAL PREPARATIONS · Now $8.45

-4.8% in 1d after detection

Post-detection moves

1h
1d
-4.8%
3d
-1.4%
7d
+4.3%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS